Pfizer is one of the world’s leading pharmaceutical companies and began its operations in India in 1950. The company is specialised with expert therapy in four business categories - Vaccines, Hospitals, Internal Medicine and Inflammation and Immunology. The company applies cutting-edge science and its global resources to bring therapies to people that extend and significantly improve their lives. The company strives to set the standard for quality, safety and value in the discovery, development, and manufacture of health care products, including innovative medicines and vaccines.
The company continuously works across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of its time. Consistent with its responsibility as one of the world's premier innovative biopharmaceutical companies, the company collaborates with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world.
Business area of the company
Pfizer is engaged in manufacturing, marketing, distribution and trading of pharmaceutical products. The company has its own manufacturing facility. The company also has various independent contract / third party manufacturers based across the country. The company sells its products primarily in India through independent distributors.
Key products
- Vaccines
- Anti-infectives
- Internal Medicine
- Inflammation and Immunology
Awards
2001
2002
2003
Voted as the 5 'Most Respected Company' in the Pharma sector (Business World).
Corporate Advertising Campaign won a Silver Award at the ABBY-All India Awards for Creative Excellence. Gelusil brand received a Silver Award for printing advertising.
Golden Peacock National Training Special Commendation for Training practices.
2004
Ranked 5 among all pharmaceutical companies, with respect to corporate image, field-force, and promotional programs (AC Nielsen-ORG Marg 'Corporate Image Survey').
Ranked 1 among all Pharma MNCs & 4 among all Pharma Companies by Business World.
Kewal Handa, CFO Pfizer receives the ‘India CFO 2004 - Excellence in Finance in an MNC’ by International Market - Assessment Group.
2005
Golden Peacock Innovative Service Award for Prime MD Today (Daxid).
PC Quest 'Best IT Implementation Users Choice' award for OPTILEARN.
Pharma Excellence Awards 2006 in 'Innovative Products of the Year' category for Exubera.
Ranked 1 among multinationals and #3 among all pharmaceuticals, in the Business World survey.
2006
Pharma Excellence Awards 2006 in 'Innovative Products of the Year' category for Exubera.
Ranked 1 among multinationals and 3 among all pharmaceuticals, in the Business World survey.
Kewal Handa, Managing Director Pfizer, awarded the Bharat Shiromani award for his outstanding contribution in the pharmaceutical industry.
2007
2008
Frost & Sullivan Brand Strategy Leadership Award for Becosules in the Indian Dietary Supplement Market.
Pfizer India was recently conferred the ‘Innovative Training Practices’ Award for promoting effective and optimum utilization of human resource through education and training by the Indian Society for Training and Development (ISTD).
2009
2010
Pfizer awarded the Most Admired Pharmaceutical Company of the Year by Pharma Leaders Magazine.
Kewal Handa, Country Manager - Pfizer recognized as Pharma Professional of the Year by Pharma Leaders Magazine.
Pfizer wins the Community Engagement Award at the Asia Responsible Entrepreneurship Awards 2010 in India.
2011
2012
2013
GBCHealth Business Leadership Award - in recognition for the Global Health Fellows program. This award is given annually to a company or business leader with a deep and long-term commitment to global health that extends beyond the business objective of the company itself. Caroline Roan will be accepting the award on behalf of Pfizer.
Business Action on Health Award in Application of Core Competence for Global Health Fellows Program (commendation). Oonagh Puglisi will be accepting the award for the GHF program.
Business Action on Health Award in Partnership/Collective Action for Advancing Cancer & Tobacco Control in China Program. Danlong Feng, Corporate Affairs Director, Pfe China, will be accepting the award.
QUESTAR Award - The International Awards Festival for Excellence in Video Communications Pfizer was awarded the Grand -- best of category -- in Annual Reports in the 2013 Questar Awards.
Telly Award - For over a quarter century, the Telly statuette has been a symbol of creative excellence. Pfizer was awarded - Bronze at the 2013 Telly's for online videos.
2017
- The company was awarded the ‘Swachhta Pharma Award’ by Union Minister, Ananth Kumar, and Union Minister of State, Mansukh Mandaviya, from the Ministry of Chemicals & Fertilizers at the flagship India Pharma 2017 conference.
2022- Winner of ‘ICAI Award for Excellence in Financial Reporting 2021-22’ in the Silver Shield category by The Institute of Chartered Accountants of India under the Manufacturing and Trading category.
2023- The company was honoured with the 2023 Pfizer Global Service Performance Award for the extraordinary efforts in making the site an amazing workplace for all.
2024- The company received the 2024 Pfizer Global Service Performance Team Award for exceptional progress in enhancing capacity utilisation and fostering a highquality work environment at the site.
Milestones:
1849: Charles Pfizer & Company established. 1' product for treatment of intestinal worms is a success.
1880: Pfizer manufactures Citric Acid. Rapid growth on the back of aerated drinks demand.
1882: Alexander Fleming discovers penicillin.
1944: Pfizer finds a way to mass-produce Penicillin.
1950: Terramycin, the 1st pharmaceutical sold in the US under the Pfizer label.
1950: India operation launched, with HQ in Mumbai.
1966: Pfizer listed on the Bombay Stock Exchange.
1989: Dolonex (Feldene) launched in India.
1993: Amlogard (Norvasc) launched in India.
1996: Launch of MinipressXL, an anti hypertensive drug.
1998: Launch of Viagra, for erectile dysfunction.
1999: Pfizer listed on the National Stock Exchange.
2000: Launch of Magna& a unique hospital antibiotic.
2002: Futuristic tablet manufacturing Goa plant commissioned in a record 13 months.
2003 Completes merger with Parke-Davis (India) Ltd.
2005: Announces merger with Pharmacia Healthcare ltd.
2006: Launch of LYRICA (pregaballn for treatment of neuropathic pain)
2008: Launch of Champix - a non-nicotine smoking cessation prescription drug.
2010: Launch of Prevenar 13, vaccine for prevention of pneumococcal disease and included later in India’s Universal Immunization Programe.
2015: Completed merger with Wyeth.
2016: Launched Xeljanz-the first oral Janus Kinase (JAK) inhibitor.
2017: Acquires 2 breakthrough brands- Meronem, Neksium.
2019: Reorganizes into 3 distinct business units: Pfizer Biopharma Group, UpJohn and Consumer Healthcare. New purpose and values unveiled.
2019: Launches novel anti-bacterial Zavicefta in India.
2020: Launch of Zinforo, a noval cephalosporin indicated for treatment of adult patients with community- acquired Pneumonia.
2021: Pfizer Inc. donated COVID-19 treatment drugs worth $70 million to India, while the Company contributed Magnex valued at around Rs 12 crore, supporting the country’s pandemic response efforts.
2024: Pfizer joined hands with NIPER (Ahmedabad) to support Healthcare Innovation in India.
2025: Pfizer launched its next-generation 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India.
2025: Pfizer has introduced Rimegepant ODT in India for adults with a previous insufficient response to triptan, the usual drugs for treating migraine.